Dexmedetomidine: A useful adjunct to consider in some high-risk situations

AANA Journal

Volumn 76, Issue 5, 2008, Pages 335-339

  Haselman, Mariann A ^a  

^a Commonwealth Anesthesia Associates ^*  (United States)

Author keywords

Adjunct; Analgesia; Anxiolysis; Dexmedetomidine; Sedation

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; CLONIDINE; DEXMEDETOMIDINE; DIGOXIN; HYPNOTIC SEDATIVE AGENT; IBUPROFEN; NORADRENALIN; OPIATE; PHENYTOIN; PRESYNAPTIC RECEPTOR; PROPRANOLOL; THEOPHYLLINE; WARFARIN;

ADRENERGIC SYSTEM; ANALGESIA; ARTIFICIAL VENTILATION; CARDIOVASCULAR EFFECT; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SELECTIVITY; DRUG STRUCTURE; GENERAL ANESTHESIA; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; OFF LABEL DRUG USE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; REGIONAL ANESTHESIA; RESPIRATION DEPRESSION; REVIEW; SEDATION; STRESS; TRANQUILIZING ACTIVITY;

ADJUVANTS, ANESTHESIA; ADRENERGIC ALPHA-AGONISTS; ANESTHESIA, GENERAL; DEXMEDETOMIDINE; HUMANS; NURSE ANESTHETISTS;

EID: 53749086162     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001;14(1):13-21.
2. Rich J. Dexmedetomidine as a sole sedating agent with local anesthesia in high-risk patient for axillofemoral bypass graft: a case report. AANA J. 2005;73(5):357-360.
3. Precedex [package insert]. North Chicago, IL: Abbott Laboratories; 2002.
4. Hoffman BB. Adrenoreceptor activing and other sympathomimetic drugs. In: Katzung B. Basic and Clinical Pharmacology. 9th ed. New York, NY: McGraw-Hill. 2003;9:134-139.
5. Bhana N, Goa K, McKlellan K. Dexmedetomidine. Drugs. 2000;59(2):263-268.
6. Roberts TL. Dexmedetomidine. J Pharm Soc Wis. November/December 2003:47-52.
7. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small dose dexmedetomidine infusions. Anesth Analg. 2000;90(3):699-705.
8. Bhatia P, Jodhpur SN. Dexmedetomidine: a new agent in anesthesia and critical care practice. http://www.theiaforum.org/apr2002.htm. Accessed May 10, 2007.
9. Special Report: Current Strategies in ICU Sedation. Abbott Laboratories 2002.
10. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93(2):382-394.
11. Dexmedetomidine. http://dexmedetomidine.com. Accessed May 10, 2007.
12. Venn R, Hell J, Ground R. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4(5):302-308.
13. Hofer R, Sprung J, Sarr M, Wedel D. Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics. Can J Anaesth. 2005;52(2):176-180.
14. Khan ZP, Ferguson CN, Jones RM. alpha-2 and imidazole receptor agonists: their pharmacology and therapeutic role. Anaesthesia. 1999; 54(2):146-165.
15. Mantz J. Dexmedetomidine. Drugs Today. 1999;35(3):151-157.
16. 2-adrenergic agonists. Anesthesiology. 2000;93(5):1345-1349.
17. Ramsey MA, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004;101(3):787-790.
18. Jalowieck P, Rudner R, Gonciarz M, Kawecki P, Petelenz M, Dziurdzik P. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology. 2005;103(3):269-273.
19. Deutsch E, Tobias JD. Hemodynamic and respiratory changes following dexmedetomidine administration during general anesthesia; sevoflurane vs desflurane. Paediatric Anaesthesia. 2007;17(5):438-444.